CP, July 2017, Vol 9, No 7

Study identifies biomarkers predicting cognitive decline in early Parkinson’s disease

Significant findings offer scope for the development of clinical trials and personalised treatments for Parkinson’s disease.…

Cancer drug shows potential in treating severe asthma

US researchers explore the effects of imatinib on reducing mast cell activity in poorly controlled asthma.…

Tamoxifen prevents high fat diet-induced obesity in mice

The oestrogen-receptor modulator widely used to treat and prevent breast cancer could help to protect against weight gain and insulin resistance, researchers find.…

Biologic medicine effective against refractory psoriatic arthritis

Trial supports the use of ixekizumab as an option for patients who are unable to take TNF inhibitors.…

Melatonin is not a long-term solution for sleep issues in children

The media has recently highlighted that the number of prescriptions for melatonin have been increasing in children and young people. This is a cause for concern and something that The Children’s Sleep Charity is working hard to address. It is, of course, important to note that there are cases …

Bevacizumab as effective as aflibercept for central retinal vein occlusion

Bevacizumab is frequently used off-label for treating macular oedema resulting from central retinal vein occlusion (CRVO), despite a lack of supporting data.…

Two doses of HPV vaccine enough to protect against genital warts

US study shows that three doses of the Human Papillomavirus vaccine does not provide any more protection than two against genital warts.…